Medicine and Dentistry
Patient
100%
Hepatitis C Virus
50%
Transplantation
40%
Interferon
40%
Recurrent Disease
40%
Liver Graft
30%
Hepatitis C
30%
Precursor
20%
Enzyme Linked Immunospot Assay
20%
Immunosuppressive Treatment
10%
Allograft
10%
Lymphocyte
10%
Interleukin 10
10%
Alloantigen
10%
Monitoring
10%
Therapeutic Procedure
10%
Liver
10%
T Cell
10%
INIS
hepatitis
80%
patients
60%
viruses
50%
transplants
40%
liver
40%
interferon
40%
precursor
20%
monitoring
10%
risks
10%
populations
10%
losses
10%
secretion
10%
immunosuppression
10%
lymphocytes
10%
interleukins
10%
reactivity
10%
Nursing and Health Professions
Donor
100%
Transplantation
40%
Recurrent Disease
40%
Interferon
40%
Liver Graft
30%
Hepatitis C
30%
Enzyme Linked Immunospot Assay
20%
Patient Population
20%
Immunosuppressive Treatment
10%
Allograft
10%
Interleukin 10
10%
Alloantigen
10%
Monitoring
10%
Immunology and Microbiology
Transplantation
70%
Hepatitis C Virus
50%
Interferon Type I
40%
Liver
40%
Hepatitis C
30%
Precursor
20%
Enzyme-Linked Immunospot Assay
20%
Secretion (Process)
10%
Allotransplantation
10%
Lymphocyte
10%
Interleukin 10
10%
Alloantigen
10%
Immunosuppression
10%